[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 7, 2000

Improving the Conduct and Reporting of Clinical Trials—Reply

Author Affiliations
 

Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Contributing EditorIndividualAuthor

JAMA. 2000;283(21):2787-2790. doi:10.1001/jama.283.21.2787

In Reply: Dr Bernhardt refers to a study that should have shown that nystatin is effective against esophageal candidiasis, but this study is an evaluation of 2537 endoscopies and not a randomized trial.1 We showed that the effect of nystatin is similar to that of placebo in immunocompromised patients. Despite this outcome, the results for amphotericin B and nystatin had been combined in 3 of the large trials we identified for our meta-analysis.

First Page Preview View Large
First page PDF preview
First page PDF preview
×